AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
11.36
+0.08 (0.71%)
At close: Sep 2, 2026, 4:00 PM EDT
11.29
-0.07 (-0.62%)
Pre-market: Sep 3, 2026, 4:00 AM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $3.68 billion as of September 2, 2026. Its market cap has increased by 194.70% in one year.
Market Cap
3.68B
Enterprise Value
3.28B
1-Year Change
194.70%
Ranking
Category
Stock Price
$11.36
ChartMarket Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $3.68B, a decrease of -76.50%. That is a compound annual growth rate of -22.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 3.68B | 259.59% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 4.11B |
| Relay Therapeutics | 4.03B |
| Legend Biotech | 4.03B |
| IDEAYA Biosciences | 3.87B |
| Tango Therapeutics | 3.85B |
| Viking Therapeutics | 3.82B |
| Denali Therapeutics | 3.80B |
| Telix Pharmaceuticals | 3.74B |